Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Trisequens
Drug ID BADD_D02299
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID C032040
PubChem ID 123634
TTD Drug ID Not Available
NDC Product Code Not Available
UNII Not Available
Synonyms Trisequens | Trisekvens | Kliogest | Kliojest
Chemical Information
Molecular Formula C58H76O8
CAS Registry Number 66100-41-2
SMILES CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C.CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4) O.CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001---
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Alopecia23.02.02.001--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Anxiety19.06.02.002--
Back pain15.03.04.005--
Blood pressure increased13.14.03.005---
Bone disorder15.02.04.004---
Breast cancer16.10.01.001; 21.05.01.003---
Breast enlargement21.05.04.001---
Breast oedema21.05.05.012---
Breast pain21.05.05.003--
Breast tenderness21.05.05.004---
Cerebral haemorrhage17.08.01.003; 24.07.04.001---
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Chloasma18.08.02.002; 23.05.01.001---
Cholelithiasis09.03.01.002---
Cyst08.03.05.001; 16.02.02.002---
Dementia17.03.01.001; 19.20.02.001---
Depression19.15.01.001--
Dermatitis23.03.04.002---
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Drug ineffective08.06.01.006---
Dyspepsia07.01.02.001--
Endometrial cancer16.12.02.001; 21.07.02.002---
Endometrial hyperplasia21.07.01.002---
Erythema multiforme10.01.03.015; 23.03.01.003--
Erythema nodosum10.02.01.020; 23.07.02.001---
The 1th Page    1 2 3    Next   Last    Total 3 Pages